Medication Management
Introduction to Olanzapine
- Olanzapine is effective for controlling problematic delusions, hallucinations, severe psychomotor agitation, and combativeness in elderly patients, as suggested by the American Family Physician 1
- The typical effective dose range for olanzapine is 7.5-20 mg/day, as recommended by the British Journal of Psychiatry and the American Psychiatric Association 2
Dosage and Administration
- The initial dose of olanzapine for elderly patients is 2.5-5 mg PO or SC, as recommended by the American College of Clinical Pharmacology 3
- The following table summarizes the recommended dose adjustments:
| Population | Recommended Dose |
|---|---|
| Elderly patients | 2.5-5 mg |
| Hepatic impairment | Reduced dose |
| Renal impairment (severe) | Reduced dose |
| Poor metabolizers of CYP2D6 | Reduced dose |
- Dose reductions are recommended in patients with hepatic impairment, renal impairment (severe), and poor metabolizers of CYP2D6, as well as in elderly patients due to higher risk of adverse effects 3, 4
- The American College of Physicians recommends avoiding concurrent use of other dopamine antagonists during the transition to prevent excessive dopamine blockade 5
- The Mayo Clinic suggests that slow tapering is preferred to minimize withdrawal symptoms and reduce relapse risk, and if withdrawal symptoms occur, slow the taper by extending the time between dose reductions to 3-4 weeks instead of 2 weeks 6
Drug Interactions and Contraindications
- The National Comprehensive Cancer Network recommends avoiding combining olanzapine with other dopamine antagonists, metoclopramide, phenothiazines, or haloperidol 5
- Combining olanzapine with benzodiazepines increases the risk of oversedation and respiratory depression, as cautioned by the American College of Clinical Pharmacology 3
- Patients with known hypersensitivity to olanzapine should not receive the medication, as it can cause rare but serious skin reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) 5
- The American Geriatrics Society warns of an increased mortality risk in elderly patients with dementia-related psychosis, advising against the use of olanzapine in such cases 3
Adverse Effects and Monitoring
- Common adverse effects of olanzapine include sedation, orthostatic hypotension, and metabolic effects with long-term use, as reported by the American College of Clinical Pharmacology 3
- Serious concerns include extrapyramidal symptoms, potential to cause delirium in some elderly patients, and falls risk, as highlighted by the American Family Physician and the Journal of the American Geriatrics Society 3, 1, 7
- Olanzapine is associated with a higher risk of type II diabetes and metabolic syndrome, as stated in the Journal of the National Comprehensive Cancer Network guidelines 5
- Regular assessment for sedation and orthostatic hypotension is necessary, as well as monitoring for extrapyramidal symptoms and assessing for metabolic effects if used long-term, as advised by the American Geriatrics Society 3
- Monitoring for weight gain, hyperglycemia, and dyslipidemia is essential, as stated in the Journal of the National Comprehensive Cancer Network guidelines 5
- Monitoring for orthostatic hypotension, especially during initial dose titration, is crucial, and patients should be assessed for fall risk at initiation and recurrently for long-term therapy 5
Special Considerations and Alternative Treatments
- For non-agitated delirium, pharmacologic treatment is not recommended, according to the Journal of the American Geriatrics Society 7
- For alcohol or benzodiazepine withdrawal, benzodiazepines are first-line, not antipsychotics, as suggested by the American College of Clinical Pharmacology and the Journal of the American Geriatrics Society 3, 7
- Other atypical antipsychotics to consider include risperidone and quetiapine, with initial doses of 0.5 mg PO and 25 mg PO, respectively, as recommended by the American College of Clinical Pharmacology 3
- The medication should be used at the lowest effective dose for the shortest duration possible, and only for severe agitation after non-pharmacological approaches have failed, as recommended by the American College of Clinical Pharmacology 3